Abdominal XXXX : role of early aggressive surgery.

@entity1 @entity706 @entity41 @entity5 @entity2109 @entity810
Current surgical teaching advocates debulking of the abdominal Burkitt's @entity706 burden and improve survival. The records of 16 @entity1 who had @entity2109 were reviewed. Eleven of these @entity1 presented with @entity5 . Five of these 11 @entity1 are long-term survivors and six have died. Three of the @entity5 were primarily resected; two were in @entity1 who became long-term survivors. One resection was complicated by @entity810 , leading to the early demise of the @entity1 . Four @entity5 were debulked; only one of these was in a long-term survivor. @entity810 also complicated the hospital course in one of these @entity1 . Finally, four @entity1 underwent initial incisional biopsies and plans were made for subsequent resection of any @entity41 6 weeks later. Two of these @entity1 survived and two have died. The results of this pilot study do not confirm that there is a clear advantage to aggressive operative cytoreduction. Although this approach decreases the total @entity5 burden, it may also impose severe metabolic complications and postpone the administration of chemotherapy. These results do suggest the need for a multi-institutional review of the surgical management of abdominal @entity2109 .
